Track MetLife, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

MetLife, Inc. MET · Stock Open MetLife, Inc. in new tab

102.65 USD
P/E
12.85
EPS
7.65
Yield
2.36%
Safety Score
100
P/B
2.79
ROE
19.92
Beta
0.77
Target Price
108.88 USD
MetLife, Inc. logo

MetLife, Inc.

🧾 Earnings Recap – Q3 2026

MetLife shares fell 3.1% after the earnings release, despite record adjusted EPS, as the quarter’s 22% EPS growth was meaningfully supported by $720 million of variable investment income, including stronger private-equity returns. That reliance on market-sensitive gains—and weaker conditions in Chile—may have tempered the reception to management’s upbeat framing.

  • Adjusted EPS excluding notable items was $2.85, up 22% year over year; adjusted earnings were $1.8 billion. The quarter included $720 million of pretax variable investment income, with private-equity returns above 4% versus 3% a year ago.
  • Adjusted ROE excluding notable items was 19.6%, above the company’s 15%–17% full-year target range; adjusted book value per share rose 5% to $59.41.
  • Group Benefits adjusted earnings excluding notable items rose 14% to $523 million. Life underwriting was favorable, and adjusted PFOs increased 5%, excluding participating contracts.
  • RIS adjusted earnings excluding notable items increased 12% to $478 million, while adjusted PFOs excluding pension risk transfers rose 33%. U.S. PRT activity has been lighter this year, though management characterized it as a timing issue.
  • Regional performance was mixed: Asia earnings rose 21% on a constant-currency basis, while Latin America’s result was affected by Chilean market conditions and a negative encaje return.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 3, 2027
P/E12.85
EPS7.65
Book Value35.22
Price to Book2.79
Debt/Equity223.77
% Insiders16.214%
Growth
Revenue Growth0.18%
Earnings Growth2.01%
Estimates
Forward P/E8.80
Forward EPS11.16
Target Mean Price108.88
Dividend
Dividend Yield2.36%
Annual dividends2.35 USD
Ex-Div. DateNov. 3, 2026
Payout32.79%
5y avg Yield3.20%

DCF valuation

Model fair value for MetLife, Inc. (MET)
Result
Sign in to run the valuation for MET.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
16 analysts · consensus Buy · mean target 108.88 USD (low 84.00, high 131.00) · as of 9 Nov 2026
Low 84.00
Mean 108.88
High 131.00
Price 102.65
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

MetLife, Inc. Logo MetLife, Inc. Analysis (MET)

United States Financials Official Website Stock

Is MetLife, Inc. a good investment? MetLife, Inc. (MET) is currently trading at 102.65 USD. Market analysts have a consensus price target of 108.88 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 12.85. This relatively low multiple may signal that MetLife, Inc. is undervalued compared to historical market norms.

Earnings Schedule: MetLife, Inc. is expected to release its next earnings report on Feb. 3, 2027. The market consensus estimate for Forward EPS is 11.16.

For income investors, MetLife, Inc. pays a dividend yield of 2.36%. With a payout ratio of 33%, the dividend appears sustainable.

Investor FAQ

Does MetLife, Inc. pay a dividend?

Yes, it pays an annual dividend of 2.35 USD (2.36% yield).

What asset class is MetLife, Inc.?

MetLife, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 3, 2027. The company currently has a trailing EPS of 7.65.

Company Profile

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Exchange Ticker
FRA (Germany) MWZ.F
NYQ (United States) MET
Trades
Dividend Yield
2.36%
5y avg 3.20%
Annual Dividends
2.35USD
Next Ex. Div Date
Nov. 3, 2026
Payout Ratio
32.79%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
1.83 USD
Sept. 14, 2027 (estimated) 0.6187
June 8, 2027 (estimated) 0.6187
March 9, 2027 (estimated) 0.5922
▸2026
2.35 USD
Dec. 8, 2026 0.5930
Sept. 8, 2026 0.5930
June 9, 2026 0.5930
March 10, 2026 0.5680
▸2025
2.25 USD
Dec. 9, 2025 0.5680
Sept. 9, 2025 0.5680
June 10, 2025 0.5680
March 11, 2025 0.5450
▸2024
2.16 USD
Dec. 16, 2024 0.5450
Sept. 10, 2024 0.5450
June 11, 2024 0.5450
March 14, 2024 0.5200
▸2023
2.06 USD
Dec. 14, 2023 0.5200
Sept. 14, 2023 0.5200
June 14, 2023 0.5200
March 14, 2023 0.5000
▸2022
1.98 USD
Dec. 14, 2022 0.5000
Sept. 14, 2022 0.5000
June 14, 2022 0.5000
March 14, 2022 0.4800
▸2021
1.90 USD
Dec. 14, 2021 0.4800
Sept. 14, 2021 0.4800
June 14, 2021 0.4800
March 15, 2021 0.4600
▸2020
1.82 USD
Dec. 14, 2020 0.4600
Sept. 14, 2020 0.4600
June 12, 2020 0.4600
March 13, 2020 0.4400
▸2019
1.74 USD
Dec. 13, 2019 0.4400
Sept. 13, 2019 0.4400
June 13, 2019 0.4400
March 13, 2019 0.4200
▸2018
1.66 USD
Dec. 13, 2018 0.4200
Sept. 13, 2018 0.4200
June 13, 2018 0.4200
March 13, 2018 0.4000
▸2017
1.60 USD
Dec. 13, 2017 0.4000
Sept. 13, 2017 0.4000
June 13, 2017 0.4000
March 13, 2017 0.4000
▸2016
1.58 USD
Dec. 13, 2016 0.4000
Sept. 13, 2016 0.4000
June 13, 2016 0.4000
March 14, 2016 0.3750
▸2015
1.48 USD
Dec. 11, 2015 0.3750
Sept. 11, 2015 0.3750
June 12, 2015 0.3750
March 13, 2015 0.3500
▸2014
1.32 USD
Dec. 12, 2014 0.3500
Sept. 12, 2014 0.3500
June 13, 2014 0.3500
March 13, 2014 0.2750
▸2013
1.01 USD
Dec. 13, 2013 0.2750
Sept. 13, 2013 0.2750
June 13, 2013 0.2750
March 13, 2013 0.1850
▸2012
0.74 USD
Dec. 14, 2012 0.7400
▸2011
0.74 USD
Dec. 14, 2011 0.7400
▸2010
0.74 USD
Dec. 14, 2010 0.7400
▸2009
0.74 USD
Dec. 14, 2009 0.7400
▸2008
0.74 USD
Dec. 15, 2008 0.7400
▸2007
0.74 USD
Dec. 14, 2007 0.7400
▸2006
0.59 USD
Dec. 15, 2006 0.5900
▸2005
0.52 USD
Dec. 15, 2005 0.5200
▸2004
0.46 USD
Dec. 13, 2004 0.4600
▸2003
0.23 USD
Dec. 15, 2003 0.2300
▸2002
0.21 USD
Dec. 13, 2002 0.2100
▸2001
0.20 USD
Dec. 14, 2001 0.2000
▸2000
0.20 USD
Dec. 15, 2000 0.2000
Upcoming Dividends
Name Payment Date Status Amount
MetLife, Inc. Dec 08, 2026 Upcoming 0.593 USD
MetLife, Inc. Sep 08, 2026 0.593 USD
MetLife, Inc. Jun 09, 2026 0.593 USD
MetLife, Inc. Mar 10, 2026 0.568 USD
Stock Splits
Split Date Split Ratio to 1
Aug. 7, 2017 1.122
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion